PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 14,117,647 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementUnderwriting Agreement • September 14th, 2018 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • New York
Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 14,117,647 shares of its common stock, par value $0.001 per share (the “Shares”). The 14,117,647 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,117,647 Shares. Such additional 2,117,647 Shares to be sold by the Company, if any, pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” Cowen and Company, LLC (“Cowen”) and Cantor Fitzgerald & Co. (“CF&CO”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Shares. To the extent
